"Headquartered in Birmingham, AL, Southern Research specializes in Drug Discovery, Drug Development, Engineering, and Energy & Environment. With more than 400 scientists and engineers, Southern Research is dedicated to finding solutions to ongoing crises while developing innovative solutions on behalf of organizations such as the National Cancer Institute, NASA, the U.S. Department of Energy and more. Our efforts are guided by our passion and the need to solve the world’s hardest problems."

During the past decade, Southern Drug Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Drug Research" #1 collaborator was "Cell Pathways" with 1 trials as a collaborator and "OSI Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southern Drug Research" are "Chronic Pain" (2 trials), "Crohn's Disease" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Southern Drug Research" in a lesser frequency.

Most popular intervention types in "Southern Drug Research" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Oxymorphone Extended Release" (2 trials), "Buprenorphine transdermal patch" (1 trials) and "CP-461" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Drug Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Southern Drug Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southern Drug Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Drug Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".